FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Pascual Marco

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Biological Markers

Procedures

Physiology

Fibrinolysis

Co-author Network

Publications

TOP 3
Francisco Marin; Vanessa Roldán; Vicente Climent; A Ibáñez; Amaya García; Pascual Marco; Francisco Sogorb; G Y H Lip
Plasma von Willebrand factor, soluble thrombomodulin, and fibrin D-dimer concentrations in acute onset non-rheumatic atrial fibrillation.
Javier Corral; James A Huntington; Rocio González-Conejero; Alec Mushunje; M Navarro; Pascual Marco; Vicente Vicente; Robin W Carrell
Mutations in the shutter region of antithrombin result in formation of disulfide-linked dimers and severe venous thrombosis.
Vanessa Roldán; Francisco Marin; Andrew D Blann; Amaya García; Pascual Marco; Francisco Sogorb; Gregory Y H Lip
Interleukin-6, endothelial activation and thrombogenesis in chronic atrial fibrillation.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Pascual Marco (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2004: Francisco Marin; Vanessa Roldán; Vicente Climent; A Ibáñez; Amaya García; Pascual Marco; Francisco Sogorb; G Y H Lip
Plasma von Willebrand factor, soluble thrombomodulin, and fibrin D-dimer concentrations in acute onset non-rheumatic atrial fibrillation.
Heart (British Cardiac Society) 2004;90(10):1162-6.
2004: Javier Corral; James A Huntington; Rocio González-Conejero; Alec Mushunje; M Navarro; Pascual Marco; Vicente Vicente; Robin W Carrell
Mutations in the shutter region of antithrombin result in formation of disulfide-linked dimers and severe venous thrombosis.
Journal of thrombosis and haemostasis : JTH 2004;2(6):931-9.
2003: Vanessa Roldán; Francisco Marin; Andrew D Blann; Amaya García; Pascual Marco; Francisco Sogorb; Gregory Y H Lip
Interleukin-6, endothelial activation and thrombogenesis in chronic atrial fibrillation.
European heart journal 2003;24(14):1373-80.
2003: Francisco Marin; Vanessa Roldán; Vicente Climent; Amaya Garcia; Pascual Marco; Gregory Y H Lip
Is thrombogenesis in atrial fibrillation related to matrix metalloproteinase-1 and its inhibitor, TIMP-1?
Stroke; a journal of cerebral circulation 2003;34(5):1181-6.
2002: Vanessa Roldán; Francisco Marin; Javier Pineda; Pascual Marco; Javier Corral; Vicente Climent; Amaya García; Juan G Martínez; Francisco Sogorb
[Annexin V levels in survivors of early myocardial infarction].
Revista española de cardiología 2002;55(12):1230-4.
2002: Vanessa Roldán; Pascual Marco; Cristina Fernández; Eliseo Pascual
Levels of tissue factor pathway inhibitor in lupus patients correlate with lupus activity and endothelial damage markers.
Haematologica 2002;87(11):1231-2.
2002: Rocio González-Conejero; Javier Corral; Vanessa Roldán; Constantino Martínez; Francisco Marin; José Rivera; Juan A Iniesta; María L Lozano; Pascual Marco; Vicente Vicente
A common polymorphism in the annexin V Kozak sequence (-1C>T) increases translation efficiency and plasma levels of annexin V, and decreases the risk of myocardial infarction in young patients.
Blood 2002;100(6):2081-6.
2002: Francisco Marin; Vanessa Roldán; Blanca Sánchez; Alberto Berenguer; Juan M Ruiz Nodar; Vicente Climent; Pascual Marco; Francisco Sogorb
Prothrombin fragment F1+2 and von Willebrand factor levels and left ventricular systolic function. Peripheral versus intracardiac blood samples.
International journal of cardiology 2002;83(3):289-90.
2002: Pascual Marco; Francisco Marin; Amaya García; Vanessa Roldán; Gregory Y H Lip
Do protein Z levels influence the prothrombotic state in atrial fibrillation?
Thrombosis research 2002;106(4-5):269-70.
2002: Amaya García; Francisco Marin; Blanca Sánchez; Vanessa Roldán; Pascual Marco
Diurnal variation in the intensity of anticoagulation in atrial fibrillation.
Stroke; a journal of cerebral circulation 2002;33(1):322-4.
2002: P Fernández; Pascual Marco; Francisco Marin; Vanessa Roldán; Francisco Sogorb
The role of tissue plasminogen activator on the progression of the coronary disease.
European heart journal 2002;23(1):88.
2001: Vanessa Roldán; Francisco Marin; P Fernández; J Luján; Juan G Martínez; Javier Pineda; Pascual Marco; Francisco Sogorb
Tissue factor/tissue factor pathway inhibitor system and long-term prognosis after acute myocardial infarction.
International journal of cardiology 2001;78(2):115-9.
2000: V Roldán; F Marín; Pascual Marco; V Climent; Juan G Martínez; José V Monmeneu; V Bodí; F S Garri
Anticoagulant therapy modifies fibrinolytic dysfunction in chronic atrial fibrillation.
Haemostasis 2000;30(4):219-24.
1999: Francisco Marin; Vanessa Roldán; José V Monmeneu; Vicent Bodí; C Fernández; Fernando García de Burgos; Pascual Marco; Francisco Sogorb
Prothrombotic state and elevated levels of plasminogen activator inhibitor-1 in mitral stenosis with and without atrial fibrillation.
The American journal of cardiology 1999;84(7):862-4, A9.
1998: Vanessa Roldán; Francisco Marin; Pascual Marco; Juan G Martínez; R Calatayud; Francisco Sogorb
Hypofibrinolysis in atrial fibrillation.
American heart journal 1998;136(6):956-60.
1996: P Fernández; Francisco Marin; Pascual Marco; Vanessa Roldán; M C García; J G Martínez; Francisco Sogorb; R Calatayud
[The fibrinolytic system in patients with dilated myocardiopathy].
Sangre 1996;41(5):351-5.
1995: Pascual Marco; J Lucas; A Alonso; J Pérez Vázquez; P Fernández; C Victoria; M C García; R Calatayud
[Antiphospholipid antibodies in women with habitual abortions. Treatment with prednisone and acetylsalicylic acid during pregnancy].
Sangre 1995;40(5):389-92.